Anopheles funestus is one of the major malaria vectors in southern Africa and several populations in this region are resistant to pyrethroids. The current study uses a microarray based approach to identify genes up-regulated in the pyrethroid resistant population, FUMOZ, from Mozambique. As the full set of detoxification genes in An. funestus are unknown, this study investigated the utility of the An. gambiae 'detox chip' to screen for differentially expressed detoxification genes in An. funestus. Differential expression of detoxification genes in three day old adult females and males from the FUMOZ resistant strain and the FANG susceptible strain was identified using the An. gambiae 'detox chip'.
Introduction
In 2008 the World Health Organization [1] reported that an estimated 247 million people are affected worldwide with malaria. Most malaria deaths occur in Africa and this situation results from both the epidemiological situation in Africa and limited control activities during the past decades. The lack of adequate health services often results in deficiencies in treatment and this is compounded by increasing drug resistance [2] .
Insecticide resistance in the mosquito vectors is increasingly impacting on malaria control interventions [3; 4] . Malaria control in southern Africa is largely based on the use of insecticide treated bed nets (ITNs) or indoor residual spraying (IRS) with pyrethroids being the insecticides of choice. There have been reports of insecticide resistance in malaria vectors in southern Africa and these include DDT and pyrethroid resistance in
Anopheles arabiensis in South Africa [5; 6] and An. funestus resistant to pyrethroids and carbamates in South Africa and Mozambique [7; 8] . The development of pyrethroid resistance in An. funestus resulted in a malaria outbreak in South Africa between 1996 and 2000 [7] .
Two major resistance mechanisms are largely responsible for insecticide resistance i.e.
target-site resistance and metabolic resistance [9] . To date there have been no reports of target site resistance to pyrethroids in An. funestus. Metabolic resistance is characterized by increased activity of detoxifying enzymes such as esterases, cytochrome P450 monooxygenases and glutathione-S-transferases (GSTs) [9; 10] . All three enzyme groups are encoded by large gene families and identifying the individual genes associated with resistance is a very laborious exercise. This task was facilitated for An. gambiae by the development of a custom microarray specifically designed to detect transcription variation in genes associated with insecticide resistance [11] . This array was named the 'detoxification chip' (detox chip'). The 'detox chip' has been utilized for screening An.
gambiae populations from Kenya and Zanzibar [11] , Benin [12] , Nigeria [13] and Ghana [14; 15] and has also been successfully used for An. arabiensis from Cameroon [16] and
An. stephensi from Dubai [17] .
Biochemical assays and synergists have been used previously to characterize the resistance mechanisms in the FUMOZ-R pyrethroid resistant strain from Mozambique [8] . These studies implicated elevated cytochrome P450 activity as the main mechanism.
This was later supported by qPCR [18] and genetic mapping studies [19] which both identified the P450 gene, CYP6P9, as being highly over-expressed in the resistant FUMOZ-R strain.
In this study we investigated the use of the An. gambiae 'detox chip' in determining potential genes associated with insecticide resistance in a southern African An. funestus resistant strain (FUMOZ-R) and a susceptible strain (FANG). Selected significantly overexpressed genes from the microarray results were validated using qPCR.
Materials and methods

Mosquito strains
Two An. funestus strains were used in this study. The FUMOZ-R strain originated from
Mozambique and has been maintained under selection pressure with permethrin. FANG ori ginates f rom Angol a and is susceptible to all known insecti cides. Details on the insecticide resistance status of these colonies can be found in the study by Hunt et al. [20] . Both strains are maintained in standard insectary conditions of 25°C with 80% relative humidity and 12 h day/night, 45 min dusk/dawn lighting cycle.
Sample preparation and microarray hybridizations
Female and male An. funestus adults were separated on day of emergence and fed on 10%
sugar solution until they were three days old (without prior exposure to pyrethroids). The transcription levels in the three day old resistant FUMOZ-R adult females were compared to the susceptible females of the same age. The same was done for the males. Each comparison in all experiments consisted of three independent biological replicates and two technical repeats which included dye swaps to control for dye bias. There were four within-array replicate spots per microarray slide. Total RNA was extracted from three batches of fifteen three day old adult females or males using the PicoPure TM RNA Isolation kit (Arcturus) according to manufacturer's instructions. Amplified mRNA (amRNA) was synthesized using the RiboAmp TM RNA Amplification Kit (Arcturus) according to manufacturer's instructions. amRNA was measured using the Nanodrop spectrophotometer (Nanodrop Technologies, Wilmington, USA) and the quality of the RNA was assessed on a 0.8% gel.
The RNA and primer mix consisting of 8µg of amRNA for each of the samples 2µl mRNA spike mix (Universal Lucidea Scorecard, Amersham), random hexamers (Invitrogen) and water was incubated for 5 minutes at 70ºC. The RNAs mix were reverse transcribed into Cy-labeled cDNAs using Cy3 or Cy5-dUTPs (Amersham), DTT, dTNTPs, RNAsin and Superscript III (Invitrogen). The samples were incubated at 50ºC for 2 ½ hours. A mixture of 1M NaOH/ 20mM EDTA was added to the labeled cDNAs to stop the reaction. The Cy-labeled cDNAs that were to be hybridized together were pooled and purified using the Cyscribe™GFX™ Purification kit (Amersham). The concentration of the cDNAs and the binding efficiencies of the Cy-dyes were determined using the Nanodrop spectrophotometer (Nanodrop Technologies, Wilmington, USA). Samples that had a low cDNA yield (<15ng/µl) and poor dye incorporation (<0.1 pmol/µl of each dye)
were discarded. 5µg of poly dA oligo (Amersham Biosciences) were added to the purified targets to reduce nonspecific hybridization. The labeled samples were dried in a speed vacuum centrifuge for 1 hour at 30ºC and re-suspended in 15.5µl of hybridization buffer (Corning). The targets were denatured by incubation at 95°C for 5 minutes. The
An. gambiae 'detox chip' was pre-treated using the Universal Hybridization kit (Corning), according to manufacturer's instructions. However the wash solutions were made up using three times the amount of components as stated in the protocol by David et al. (2005) . The target mix was added to the microarray chip and hybridizations were performed at 38°C for 16 hours.
After the incubation the slides were washed using the Universal Hybridization kit (Corning). The slides were pre-soaked in wash solution 1 for one to two minutes at 38°C, followed by a second wash of solution 1 for 2 ½ minutes and finally incubated in wash solution 2 at ambient temperature for 5 minutes. The slides were subjected to three washes in fresh wash solution 3 at ambient temperature for one minute. Excess wash solution was removed from the slides by centrifugation at 2500 rpm for two minutes.
Microarray scanning and data analysis
The slides were scanned using the Genepix 4000B scanner (Molecular Devices, USA),
where the PMT values were adjusted to give a ratio of 1/1. The quality of spots and background intensities were examined and corrected using the Genepix Pro 6.0 software (Axon instruments, USA).
The raw intensity values were analyzed using the limma software package version 2.12.0, from the BioConductor project, in the R programming environment [21] . Image plots were generated to inspect the variation of background values across the arrays.
Background correction was carried out using the 'normexp' method [22] with an offset of 50. Within array normalization was performed, using the 'control' method in limma to fit a global loess curve through a set of non-differentially expressed control spots. This curve was applied to all the other spots, thereby normalizing the M-values for each array separately [23] . Between array normalization was performed using the 'Aquantile' method to ensure that the A values have the same empirical distribution across arrays. To visualize the effect of normalization, MA-plots were used. The limma package uses empirical Bayes analysis to assess differential expression, by calculating a B-statistic, a moderated t-statistic and an adjusted p-value for each gene [24] . A top table was generated which revealed the highly differentially expressed genes for both the strains of interest. Genes exhibiting adjusted p-values <0.001 and fold-changes ≥1.5 were considered as statistically significant over-expressed genes. The data was deposited into the vectorbase database (https://www.vectorbase.org).
Quantitative Real Time PCR (qPCR)
Quantitative PCR analysis was carried out on three day old FUMOZ-R and FANG females and males to verify the results obtained from the microarray experiments. qPCR was only carried out on the three up-regulated genes in the females, and the same was done for the males. The remaining up-regulated genes in the males will be carried out in future studies. Primers were designed for genes CYP6M7 and COI. The primer pair used for the CYP6P9 gene was a gene-specific primer set [25] subsequent to the discovery of a duplicate gene, CYP6P13 [26] . The cDNA probe sequence was aligned to both the CYP6P13 (GenBank accession number: EF152577) and CYP6P9 (GenBank accession number: EU450763) gene. The cDNA probe on the microarray slide had a 81% sequence identity to both CYP6P9 and CYP6P13. Due to sequences similarities between CYP6P9
and CYP6P13, gene-specific primers were used for both CYP6P13 and CYP6P9.
RNA Isolation
The RNA samples obtained from the extractions used in the microarray experiments were used for the qPCR part of the study. The samples were quantified using a Nanodrop ® Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA).
cDNA synthesis
Total RNA was converted to cDNA using the High Capacity RNA-to-cDNA kit (Applied Biosystems, 4387406). The quality and quantity of cDNA was measured using the Nanodrop ® Spectrophotometer (Nanodrop Technologies, Wilmington, DE, USA) and the cDNA samples were stored at -70ºC until further use.
Primer Design
Primer sequences for CYP6P9 and CYP6P13 were obtained from the Christian et al. [25] study. Primers were designed for the CYP6M7 (Accession number: AY729660.1) and COI (Accession number: AY423059.1) genes using the An. funestus gene sequences.
These primers were designed using Beacon Designer 3.0 software (Biorad, Hercules, CA, USA). The rsp 7 (EF450776) primers was used as a reference gene to normalize data.
Two different sets of primers were designed for the CYP6M7 gene (Table 1 ). However amplification of the product was unsuccessful after numerous attempts to optimize the cycling conditions, primer and cDNA concentrations.
Quantification of CYP6P9, CYP6P13, CYP6M7 and COI
The qPCR experiments were performed using the Bio-Rad CFX96™ Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). A total volume of 25µl containing 12.5µl IQ™ SYBR supermix (Bio-Rad, 1708882), 4µl primer (2.5µM), 1µl cDNA (50ng) was used per reaction. A 2-fold serial dilution of cDNA was used for the standard curve reaction. Serial dilutions of cDNA for the standard curve were prepared. The cycling conditions for each primer set are presented in Table 1 . Each biological sample was repeated three times on a plate. Three biological repeats were done on different days. The data was analyzed using the relative quantification method [27] .
Results
A previous study [25] has shown that both females and males from the resistant strain, FUMOZ-R, are resistant to permethrin, although mortality rates varied between the two sexes. Therefore gene expression was determined in both three day old adult females and males of the An. funestus FUMOZ-R (resistant) and FANG (susceptible) strains using the An. gambiae 'detox chip'. Minor adjustments to the original protocol were made in order to maximize hybridization of the targets to the chip. The hybridization temperature was reduced from 42ºC to 38ºC and lower stringency wash buffers and shorter washing times were used. These optimized conditions were similar to those used for cross-species hybridization to An. stephensi [17] . After optimization of the hybridization conditions over 90% of the spots on the slide were detected as opposed to 55% obtained when using the more stringent original hybridization conditions described by David et al. [11] . The percentage of probes detected was obtained by manually counting the number of fluorescent spots on the slides after hybridization.
Genes were considered to be differentially expressed if they demonstrated a ≥1.5-fold change in expression between the two strains and a p-value of <0.001 over the entire experiment. Out of a total of 254 gene probes on the An. gambiae 'detox chip', 1.18% of genes were significantly differentially expressed in the females as opposed to 9.45% in A total of 24 genes were significantly differentially expressed in males from the resistant FUMOZ-R strain (Table 2 ). Fifty percent of these genes (n=12) belonged to the cytochrome P450 enzyme group, 17% (n=4) to the glutathione-S-transferase, 8% (n=2) to the Copper-Zinc (Cu-Zn) superoxide dismutase, 8% (n=2) to the thioredoxin group and the remaining 17% (n=4) to other groups. Three genes that were differentially expressed and common to both sexes include the cytochrome P450 genes, CYP6P9 (6.0-fold), CYP6M7 (3.6-fold) and cytochrome oxidase I, COI (2.9-fold) ( Figure 2 ). Other differentially expressed genes in the males are shown in Table 2 . Out of a total of 254 genes on the An. gambiae 'detox chip', 18 probes failed to produce any signal on the array ( (Table 4 ). All genes had a percentage similarity of >40%. The genes with the highest percentage similarity were genes CYP6P9 (81%), CYP6P13
(81%), CYP6M1 (79.4%) and CYP6P4 (75.0%). Surprisingly no signal was detected for CYP6P4 despite the 75% sequence similarity between the two species.
The low level of sequence identity between some of the probes and their putative target genes in An. funestus suggests that some care should be taken in the interpretation of the results, particularly given the high level of sequence identity between some detoxification genes in the same species [18] . The possibility that the microarray results are confounded Table 3 List of genes that did not hybridize onto the An. gambiae 'detox chip' in both the females and males of the resistant and susceptible An. funestus strain, FUMOZ-R and FANG.
Gene Name Group Vectorbase accession number
CYP306A1
Cytochrome P450 AGAP004665
CYP6P4
Cytochrome P450 AGAP002867
CYP4C28
Cytochrome P450 AGAP010414
CYP305A3
Cytochrome P450 AGAP005657
CYP6Z2
Cytochrome P450 AGAP008218
SOD3B
Superoxide dismutase AGAP010347
GSTD4
Glutathione Stransferase AGAP004381
GSTD3
Glutathione Stransferase AGAP004382
COEAE1G
Carboxylesterases AGAP006700
COEJHE1E
Carboxylesterases AGAP005833
COEunkn Carboxylesterases AGAP011509
COEAE1F
Carboxylesterases AGAP006227
COEAE7G
Carboxylesterases AGAP006728
COEBE2O
Carboxylesterases AGAP001101
COEBE4C
Carboxylesterases AGAP005370
HPX7
Peroxidase AGAP004036
HPX5A
Peroxidase AGAP000051
SP21408
Serine protease AGAP004015
by cross hybridization of probes to multiple genes can not be excluded. Therefore qPCR was performed to validate the results from the genes found over-expressed in both sexes. 
Validation
Quantitative PCR (qPCR) was used to validate the microarray results for the three genes over-expressed in both sexes. The up-regulation of CYP6P9 and COI in the resistant FUMOZ-R strain in both males and females is presented in Figure 3A and Figure 3B respectively. The resistant males showed a fold change of 51 for the CYP6P9 gene, 15 for CYP6P13 and one for COI when qPCR analysis was performed. The females also showed the highest fold change in CYP6P9 (67), followed by CYP6P13 (8) and 4 for the COI gene. Two sets of primers were designed for the CYP6M7 gene based on sequence information from the partial sequence of this An. funestus gene [18] ( Table 1 ). However amplification of the product was unsuccessful for both primers even after numerous attempts.
Discussion
Gene expression in three day old An. funestus females and males was determined using the An. gambiae 'detox chip' developed by David et al. [11] . This study used crossspecies (heterologous) hybridization of the An. funestus samples to an An. gambiae microarray platform due to the fact that unlike An. gambiae, a fully sequenced genome for An. funestus is currently unavailable. Many studies have successfully evaluated gene expression using non species-specific arrays due to lack of availability of arrays. Moody et al. [28] used human microarrays to study the gene expression in pigs. They found that the reproducibility of microarray hybridization of pig cDNA to human microarrays was high. Cross-species hybridization has also been conducted on rhesus macaque monkeys using a human high-density Affymetrix oligonucleotide array [29] . These results confirmed that a large number of genes were differentially expressed, thereby validating the use of cross-species hybridizations for nonhuman primate studies. Adjaye et al. [30] used human and bovine fetal brain target samples on a human cDNA microarray.
Differentially expressed genes were obtained and the study proved that using tissues from across species to identify co-expressed orthologous genes on a human microarray platform is possible.
The An. gambiae 'detox chip' has been successfully used to determine the transcriptional analysis of pyrethroid resistance in An. stephensi [17] and An. arabiensis [16] . This is the first study to employ microarrays to determine the genetic basis of pyrethroid resistance in An. funestus. The heterologous hybridization approach was used successfully in this study and approximately 90% probes were detected. Three genes were differentially expressed in both sexes, CYP6M7, CYP6P9 and COI; COI, CYP6P9 and its duplicate gene CYP6P13, were confirmed to be over-expressed using qPCR analysis. Although statistically the gene expression for the COI gene is different between the two methods for the males, the gene was still differentially expressed in the resistant strain. Although the over-expression of COI is not significantly high, the role of this gene needs to be investigated.
The fact that CYP6M7 could not be amplified from An. funestus mRNA could possibly imply that it is a pseudogene. However, the lower hybridization stringencies can result in hybridization of another closely related P450 gene to the CYP6M7 probe. This hypothesis can only be validated when a full genome of An. funestus is available. Wondji et al. [19] also attempted to amplify the CYP6M7 gene using a different primer set from the ones used in this study and also failed to obtain amplicons. The CYP6M7 gene needs to be further investigated.
The CYP6P9 gene has been implicated in playing a role in insecticide resistance in An.
funestus. In 2008, Amenya et al. [31] found the CYP6P9 gene to be over-expressed in the egg and adult stages of a pyrethroid resistant laboratory strain (FUMOZ-R) originating from southern Mozambique. Wondji et al. [32] identified a quantitative trait locus (QTL) associated with pyrethroid resistance in the same An. funestus strain. He found that these QTL markers contained a cluster of P450 genes including CYP6P9 a n d t h a t t h e chromosomal position of CYP6P9 is associated with permethrin resistance. In 2009 the same author [19] reported that the CYP6P9 gene was 25 times over-expressed in the FUMOZ-R strain in females and that it was tandemly duplicated and this was suggested to contribute to insecticide resistance. Interestingly the CYP6P3 (An. gambiae ortholog)
was also found to be differentially expressed (2.82-fold) in field caught An. gambiae adults from Ghana [15] . The CYP6P3 gene was also found at significantly high levels (2.6-fold) in An. arabiensis adults from Cameroon [16] .
The observation that additional genes were up-regulated in males than in females in the FUMOZ-R strain was surprising given that resistance is higher in females than males of this strain [25] . It is possible that these 21 additional differentially expressed genes are unrelated to the resistance phenotype. It is interesting to note that several of them are putatively involved in the oxidative stress response (superoxide dismutases (SOD) [33; 34; 35] , thioredoxins (TRX) [36] , glutathione-S-transferases (GSTs) [37; 38; 39] .
Eighteen probes did not hybridize to the RNA target. A large portion of those probes (38%), belong to the COE group with 28% from the P450 family. This could be due to the reduced sequence similarity between An. gambiae and An. funestus and also these genes may be present in the larval stages of the mosquito life cycle and not in the adult stage. Surprisingly two P450 genes, CYP6P4 and CYP6P1, which were significantly differentially expressed in a study by Wondji et al. [19] , did not hybridize to the array.
The CYP6P1 and CYP6P4 genes have been shown to have amino acid identities to that of An. gambiae, 82% and 89% respectively on small partial sequences analysis [18] . It is unknown why these genes did not hybridize to the slide. This needs to be investigated further.
Conclusions
The An. gambiae 'detox chip' provided valuable information in identifying potential genes involved in insecticide resistant in An. funestus. We acknowledge the fact that heterologous hybridization is most likely an under representation of the detoxifying genes that are differentially expressed, but it is currently the only tool available to use to screen multiple probes at once. This is a useful and an inexpensive alternative given that the development of a species-specific array will require genome sequencing of the specific species to be investigated and a An. funestus genome was not available at the time. This information will ultimately be used to understand the underlying mechanisms involved in resistance of this important malaria vector and hence aid in the control of effective resistant management.
